Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX) for Patients With Hepatitis C Virus Infection

NCT05092074 · clinicaltrials.gov ↗

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis C Virus Infection
Treatment Side Effects
Adherence, Treatment
Effect of Drug

Interventions

DRUG: Vosevi 400/100/100 Oral Tablet

Sponsor

National Taiwan University Hospital